Venkataraman Balasubramanian
Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )
Most Active Art Unit | 1624 |
Art Unit(s) | 1624, 1611 |
Total Applications | 2999 |
Issued Applications | 2017 |
Pending Applications | 254 |
Abandoned Applications | 728 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7688872
[patent_doc_number] => 20070105826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Novel fusidic acid derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/563103
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31163
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105826.pdf
[firstpage_image] =>[orig_patent_app_number] => 10563103
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/563103 | Novel fusidic acid derivatives | Jul 8, 2004 | Abandoned |
Array
(
[id] => 401244
[patent_doc_number] => 07291609
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-06
[patent_title] => 'Specific glucocorticosteroid compound having anti-inflammatory activity'
[patent_app_type] => utility
[patent_app_number] => 10/564299
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6743
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/291/07291609.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564299
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564299 | Specific glucocorticosteroid compound having anti-inflammatory activity | Jul 8, 2004 | Issued |
Array
(
[id] => 7351665
[patent_doc_number] => 20040248870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'High-purity composition comprising (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one'
[patent_app_type] => new
[patent_app_number] => 10/887397
[patent_app_country] => US
[patent_app_date] => 2004-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3165
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248870.pdf
[firstpage_image] =>[orig_patent_app_number] => 10887397
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/887397 | High-purity composition comprising (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one | Jul 7, 2004 | Abandoned |
Array
(
[id] => 256551
[patent_doc_number] => 07576226
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-18
[patent_title] => 'Process of making isomers of norelgestromin and methods using the same'
[patent_app_type] => utility
[patent_app_number] => 10/879710
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15002
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/576/07576226.pdf
[firstpage_image] =>[orig_patent_app_number] => 10879710
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/879710 | Process of making isomers of norelgestromin and methods using the same | Jun 29, 2004 | Issued |
Array
(
[id] => 439603
[patent_doc_number] => 07259186
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-21
[patent_title] => 'Salts of fenofibric acid and pharmaceutical formulations thereof'
[patent_app_type] => utility
[patent_app_number] => 10/880851
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16505
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/259/07259186.pdf
[firstpage_image] =>[orig_patent_app_number] => 10880851
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/880851 | Salts of fenofibric acid and pharmaceutical formulations thereof | Jun 29, 2004 | Issued |
Array
(
[id] => 7034253
[patent_doc_number] => 20050032763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Process for the synthesis of high purity D-(17a)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one oxime'
[patent_app_type] => utility
[patent_app_number] => 10/879708
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11243
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032763.pdf
[firstpage_image] =>[orig_patent_app_number] => 10879708
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/879708 | Process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime | Jun 29, 2004 | Issued |
Array
(
[id] => 7256416
[patent_doc_number] => 20050143352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Substituted tetracycline compounds'
[patent_app_type] => utility
[patent_app_number] => 10/877928
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21220
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20050143352.pdf
[firstpage_image] =>[orig_patent_app_number] => 10877928
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/877928 | Substituted tetracycline compounds | Jun 24, 2004 | Abandoned |
Array
(
[id] => 892626
[patent_doc_number] => 07345183
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-18
[patent_title] => 'Process for obtaining norelgestromin in different relations of isomers E and Z'
[patent_app_type] => utility
[patent_app_number] => 10/877858
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2299
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/345/07345183.pdf
[firstpage_image] =>[orig_patent_app_number] => 10877858
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/877858 | Process for obtaining norelgestromin in different relations of isomers E and Z | Jun 24, 2004 | Issued |
Array
(
[id] => 6997396
[patent_doc_number] => 20050137174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Prodrugs of 9-aminomethyl tetracycline compounds'
[patent_app_type] => utility
[patent_app_number] => 10/877454
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11342
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20050137174.pdf
[firstpage_image] =>[orig_patent_app_number] => 10877454
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/877454 | Prodrugs of 9-aminomethyl tetracycline compounds | Jun 24, 2004 | Abandoned |
Array
(
[id] => 6931697
[patent_doc_number] => 20050282732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Pharmaceutical compositions and treatment methods-7'
[patent_app_type] => utility
[patent_app_number] => 10/876957
[patent_app_country] => US
[patent_app_date] => 2004-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 112210
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282732.pdf
[firstpage_image] =>[orig_patent_app_number] => 10876957
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/876957 | Pharmaceutical compositions and treatment methods-7 | Jun 23, 2004 | Abandoned |
Array
(
[id] => 471039
[patent_doc_number] => RE039678
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2007-06-05
[patent_title] => 'Meiosis regulating compounds'
[patent_app_type] => reissue
[patent_app_number] => 10/870902
[patent_app_country] => US
[patent_app_date] => 2004-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27467
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 447
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/039/RE039678.pdf
[firstpage_image] =>[orig_patent_app_number] => 10870902
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/870902 | Meiosis regulating compounds | Jun 16, 2004 | Issued |
Array
(
[id] => 7351655
[patent_doc_number] => 20040248867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives'
[patent_app_type] => new
[patent_app_number] => 10/480071
[patent_app_country] => US
[patent_app_date] => 2004-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12267
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248867.pdf
[firstpage_image] =>[orig_patent_app_number] => 10480071
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/480071 | Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives | Jun 14, 2004 | Abandoned |
Array
(
[id] => 7266070
[patent_doc_number] => 20040243606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Hormonal contraceptive product'
[patent_app_type] => new
[patent_app_number] => 10/867954
[patent_app_country] => US
[patent_app_date] => 2004-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3496
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20040243606.pdf
[firstpage_image] =>[orig_patent_app_number] => 10867954
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/867954 | Hormonal contraceptive product | Jun 14, 2004 | Abandoned |
Array
(
[id] => 7319653
[patent_doc_number] => 20040225140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Pharmaceutical composition for the treatment of psoriasis and other skin diseases'
[patent_app_type] => new
[patent_app_number] => 10/865991
[patent_app_country] => US
[patent_app_date] => 2004-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1949
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20040225140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10865991
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/865991 | Pharmaceutical composition for the treatment of psoriasis and other skin diseases | Jun 10, 2004 | Abandoned |
Array
(
[id] => 7319019
[patent_doc_number] => 20040224932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Novel anti-inflammatory androstane derivative compositions'
[patent_app_type] => new
[patent_app_number] => 10/863878
[patent_app_country] => US
[patent_app_date] => 2004-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 22316
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224932.pdf
[firstpage_image] =>[orig_patent_app_number] => 10863878
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/863878 | Novel anti-inflammatory androstane derivative compositions | Jun 7, 2004 | Abandoned |
Array
(
[id] => 7378108
[patent_doc_number] => 20040220162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Compounds useful in the manufacture of an anti-inflammatory androstane derivative'
[patent_app_type] => new
[patent_app_number] => 10/862692
[patent_app_country] => US
[patent_app_date] => 2004-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17228
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220162.pdf
[firstpage_image] =>[orig_patent_app_number] => 10862692
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/862692 | Compounds useful in the manufacture of an anti-inflammatory androstane derivative | Jun 6, 2004 | Abandoned |
Array
(
[id] => 7319018
[patent_doc_number] => 20040224931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Compounds useful in the manufacture of an anti-inflammatory androstane derivative'
[patent_app_type] => new
[patent_app_number] => 10/862555
[patent_app_country] => US
[patent_app_date] => 2004-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17250
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224931.pdf
[firstpage_image] =>[orig_patent_app_number] => 10862555
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/862555 | Compounds useful in the manufacture of an anti-inflammatory androstane derivative | Jun 6, 2004 | Issued |
Array
(
[id] => 7378073
[patent_doc_number] => 20040220157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Compounds useful in the manufacture of an anti-inflammatory androstane derivative'
[patent_app_type] => new
[patent_app_number] => 10/862792
[patent_app_country] => US
[patent_app_date] => 2004-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17260
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220157.pdf
[firstpage_image] =>[orig_patent_app_number] => 10862792
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/862792 | Compounds useful in the manufacture of an anti-inflammatory androstane derivative | Jun 6, 2004 | Issued |
Array
(
[id] => 7319029
[patent_doc_number] => 20040224934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Compounds useful in the manufacture of an anti-inflammatory androstane derivative'
[patent_app_type] => new
[patent_app_number] => 10/862793
[patent_app_country] => US
[patent_app_date] => 2004-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17249
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224934.pdf
[firstpage_image] =>[orig_patent_app_number] => 10862793
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/862793 | Compounds useful in the manufacture of an anti-inflammatory androstane derivative | Jun 6, 2004 | Abandoned |
Array
(
[id] => 630571
[patent_doc_number] => 07132532
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-07
[patent_title] => 'Compounds useful in the manufacture of an anti-inflammatory androstane derivative'
[patent_app_type] => utility
[patent_app_number] => 10/862591
[patent_app_country] => US
[patent_app_date] => 2004-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16988
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/132/07132532.pdf
[firstpage_image] =>[orig_patent_app_number] => 10862591
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/862591 | Compounds useful in the manufacture of an anti-inflammatory androstane derivative | Jun 6, 2004 | Issued |